Guo‐Liang Shen
- Geriatrics and Gerontology top 10%
-
- Immunotherapy and Immune Responses 5
-
- Cancer-related molecular mechanisms research 6
-
- Cancer Immunotherapy and Biomarkers 7
- Pancreatic and Hepatic Oncology Research 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
-
- Ferroptosis and cancer prognosis 6
-
- Melanoma and MAPK Pathways 6
- Epigenetics and DNA Methylation 5
- Co-authors
- Wei HanDefei HongJunwei LiuEllen S. VitettaAlex N. F. BrownJonathan W. UhrPhillip P. KnowlesJialing Li
- Journals
- The Journal of Immunology (1 paper)Scientific Reports (4 papers)International Journal of Cancer (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Guo‐Liang Shen
42 papers receiving 461 citations
Peers
Comparison fields: 5 of 79
- Geriatrics and Gerontology 26
- Immunology 135
- Cancer Research 89
- Oncology 149
- Biotechnology 43
Countries citing papers authored by Guo‐Liang Shen
This map shows the geographic impact of Guo‐Liang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Liang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Liang Shen more than expected).
Fields of papers citing papers by Guo‐Liang Shen
This network shows the impact of papers produced by Guo‐Liang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Liang Shen. The network helps show where Guo‐Liang Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guo‐Liang Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 10 | |
| 16 | 2015 | 16 | |
| 17 | 2014 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 1994 | 12 | |
| 20 | 1988 | 64 |
About Guo‐Liang Shen
Guo‐Liang Shen is a scholar working on Hepatology, Cancer Research and Oncology, having authored 48 papers that have together received 464 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Ferroptosis and cancer prognosis (6 papers), Melanoma and MAPK Pathways (6 papers), Cancer-related molecular mechanisms research (6 papers), Immunotherapy and Immune Responses (5 papers), Epigenetics and DNA Methylation (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Geriatrics and Gerontology (26 citations), Immunology (135 citations) and Cancer Research (89 citations). Guo‐Liang Shen has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Wei Han, Defei Hong, Junwei Liu, Ellen S. Vitetta, Alex N. F. Brown, Jonathan W. Uhr, Phillip P. Knowles, Jialing Li, Philip E. Thorpe and Maria‐Ana Ghetie. Their work appears in journals such as The Journal of Immunology, Scientific Reports and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.